Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1248
| Despition | Mitofusin 2 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1080 | GABA B Receptor 2 Blocking Peptide (AC1080) | 250 µg | inquiry |
| ACPP-1085 | Recombinant Human alpha Internexin Protein (AC1085) | 25 µl | inquiry |
| ACPP-1323 | FYN Blocking Peptide (AC1323) | 250 µg | inquiry |
| ACPP-1730 | Human S100A8 Protein, His (AC1730) | 2 µg | inquiry |
| ACPP-1423 | Human ALDH5A1 Protein (AC1423) | 2 µg | inquiry |
| ACPP-1019 | Recombinant Human GPRC5A Protein (Fc Tag) (AC1019) | 50 µg | inquiry |
| ACPP-1144 | Synthetic Nanodisc Human GIPR Protein (AC1144) | 10 µg | inquiry |
| ACPP-1454 | Human PICK1 Protein (AC1454) | 2 µg | inquiry |
| ACPP-1166 | Recombinant Human VCAM1 Protein (Fc Tag) (AC1166) | 50 µg | inquiry |
| ACPP-1345 | DISC1 Blocking Peptide (AC1345) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.